The Board of Prescient Therapeutics Limited announced the appointment of leading biotechnology executive Dr. Allen Ebens, a 24 year veteran drug developer including experience with one of the most successful CAR-T companies, as a Non-Executive Director, effective 1 June 2020. Dr. Ebens is Chief Science Officer at Vera Therapeutics, a San Francisco California based biotechnology company. Dr. Ebens is a highly accomplished drug developer, having overseen the advancement of multiple successful drug development projects from concept to clinical development including polatuzumab, which is approved by the US FDA and is now marketed for use in diffuse large B-cell lymphoma.